News

SuperSeton enLIGHTens ASCRS ! 

We’d 💛 to see you at THRIVE!

The American Dream… just became knotless!

Come see the knotless future in Vilnius!

Smooth, SIMPLE, secure: Treating fistulas the easy way.

Improve your patients’ lives – one seton at a time

Master the SuperSeton at ECC St Gallen

Meet SuperSeton at booth #1 at ESCP in Dublin and claim your free samples

Bright times ahead for SuperSeton

SuperSeton is looking forward to meet you at ECC St Gallen

SuperSeton at events in Australia and Austria

Smooth, Simple, Secure: SuperSeton tensile test

SuperSeton goes global with Bridgehead Global Programme

SuperSeton selected for the HUB program, preparing US entry

We wish you a smooth 2021!

SuperSeton Publication: Scientific Report by Nature Publishing Group

Challenging times – competitive prices

SuperSeton slides smoothly into the new year at ACM Valbella 2020!

SuperSeton continues touring Europe – on to ECC in St. Gallen and EIT Health in Paris

SuperSeton Expands Its European Network – Meet Our New Partners

SuperSeton receives innovation loan from Rabobank

ESCP’s visitors embrace the SuperSeton!

Meet us at the ESCP in Vienna and try out the SuperSeton

SuperSeton expanding its European activities

SuperSeton European tour – coming to a congress near you!

SuperSeton production commenced – first shipment in May

Positive reception for SuperSeton at IBD-patient day 2019

Launch of SuperSeton product during DDD Congress in the Netherlands

SuperSeton European Market launch at Alpine Colorectal meeting

SuperSeton CE certified

Super Seton Secures Series-A

SuperSeton secures Rabobank financing

Super Seton Secures Series-A

Super Seton announces the closing of a series A share issue. The investors are two experienced Healthtech entrepreneurs, Bart Bergstein & Michiel Manuel, who will join the advisory board of the company. SuperSeton is an innovative knotless seton for use in perianal fistula and has been developed by the Amsterdam UMC (Amsterdam University Medical Centre), MediShield and NLC | the Healthtech Venture Builder. The product is expected to be launched in 2018, following CE marking. For more information contact Ernst Elhorst, CEO.

Please select your location

So we can serve you the relevant information about SuperSeton for your region.